SRPK2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.72649672336433E-11 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.63880000014771E-07 |
Normal-vs-Stage2 |
1.967020E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.386380E-02 |
Stage1-vs-Stage2 |
1.852980E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.376600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.803400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.69019967097984E-10 |
Normal-vs-AfricanAmerican |
1.07340025756741E-10 |
Normal-vs-Asian |
3.920200E-02 |
Caucasian-vs-AfricanAmerican |
7.106000E-02 |
Caucasian-vs-Asian |
5.885000E-01 |
AfricanAmerican-vs-Asian |
1.302290E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.63279999995958E-06 |
Normal-vs-Female |
9.3094999997767E-07 |
Male-vs-Female |
5.824200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.282500E-03 |
Normal-vs-Extreme_Weight |
1.03149999997054E-06 |
Normal-vs-Obese |
2.338000E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
4.346600E-01 |
Normal_Weight-vs-Obese |
8.775800E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.166820E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.686400E-01 |
Normal-vs-Age(41-60Yrs) |
4.38110000000602E-06 |
Normal-vs-Age(61-80Yrs) |
9.89020000008445E-07 |
Normal-vs-Age(81-100Yrs) |
3.517000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.984400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.750420E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.157800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.905790E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.033000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.286800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.886800E-01 |
Normal-vs-Grade 3 |
2.768800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.519420E-01 |
Grade 2-vs-Grade 4 |
5.886800E-01 |
Grade 3-vs-Grade 4 |
2.768800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.79209996737018E-09 |
Normal-vs-N1 |
2.258200E-02 |
N0-vs-N1 |
5.556300E-02 |
|
|